Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The galanin receptor family comprises three G protein–coupled receptor subtypes (GALR1, GALR2, and GALR3) that mediate the effects of the neuropeptide galanin. These receptors are widely expressed in the nervous system and regulate diverse physiological processes, including energy metabolism, pain modulation, and sleep homeostasis. They represent potential therapeutic targets for a range of neurological and metabolic disorders.
Agonism or antagonism of galanin receptors, modulation of G protein signaling pathways.
13 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Galanin Receptor (GALR).